These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 32669875)

  • 1. The Efficiency of Type-Specific High-Risk Human Papillomavirus Models in the Triage of Women with Atypical Squamous Cells of Undetermined Significance.
    Wang Y; Gao S; Wang Y; Chen F; Deng H; Lu Y
    Cancer Manag Res; 2020; 12():5265-5275. PubMed ID: 32669875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China.
    Pan D; Dong B; Gao H; Mao X; Xue H; Sun P
    Risk Manag Healthc Policy; 2020; 13():1747-1756. PubMed ID: 33061708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Different Combination Models of High-Risk HPV Genotyping in Triaging Chinese Women With Atypical Squamous Cells of Undetermined Significance.
    Guo Z; Jia MM; Chen Q; Chen HM; Chen PP; Zhao DM; Ren LY; Sun XB; Zhang SK
    Front Oncol; 2019; 9():202. PubMed ID: 31001472
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
    Guo Z; Zhao DM; Zhang SK; Wu ZN; Sun XB; Jia MM; Chen Q; Guo LW; Chen PP; Zhang JG
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1094-1099. PubMed ID: 34695901
    [No Abstract]   [Full Text] [Related]  

  • 5. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
    Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results.
    Xue H; Gao H; Zheng J; Chen Y; Chen J; Pan D; Dong B; Sun P
    J Cancer; 2021; 12(14):4332-4340. PubMed ID: 34093833
    [No Abstract]   [Full Text] [Related]  

  • 8. [The clinical performance of high risk HPV DNA test among triage women with cytology showing atypical squamous cells of undetermined significance].
    Zhang SK; Zhao DM; Chen HM; Guo Z; Ren LY; Jia MM; Chang JJ; Chen PP; Liu SZ; Sun XB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Sep; 52(9):941-945. PubMed ID: 30196643
    [No Abstract]   [Full Text] [Related]  

  • 9. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z; Li Y; Chen A; Song M; Zhang Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
    Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan.
    Tshomo U; Franceschi S; Tshokey T; Tobgay T; Baussano I; Tenet V; Heideman DAM; Snijders PJF; Clifford GM
    Oncotarget; 2017 Sep; 8(42):72438-72446. PubMed ID: 29069800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.
    Song F; Du H; Wang C; Huang X; Qu X; Wei L; Belinson JL; Wu R;
    J Med Screen; 2021 Sep; 28(3):318-324. PubMed ID: 32869705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient combination of Human Papillomavirus Genotyping for the triage of women with Atypical Squamous Cells of Undetermined Significance in Chinese rural population: A population-based study.
    Wang W; Zhang H; Lin L; Yang A; Yang J; Zhao W; Wang Z; Zhang L; Su X; Wang Z; Wang C; Zhang H; Feng B; Li D; Liu H; Niu X; Wang J; Song J; Li L; Lv W; Zhao C; Hao M
    J Cancer; 2021; 12(10):2815-2824. PubMed ID: 33854582
    [No Abstract]   [Full Text] [Related]  

  • 14. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the performance of reflex Human Papilloma Virus (HPV) testing in triaging women with atypical squamous cells of undetermined significance (ASCUS): A restrospective study in a tertiary hospital in United Arab Emirates (UAE).
    Fakhreldin M; Elmasry K
    Vaccine; 2016 Feb; 34(6):823-30. PubMed ID: 26747717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
    Layfield LJ; Qureshi MN
    Diagn Cytopathol; 2005 Aug; 33(2):138-43. PubMed ID: 16007672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
    Tropé A; Sjøborg KD; Nygård M; Røysland K; Campbell S; Alfsen GC; Jonassen CM
    J Clin Microbiol; 2012 Jun; 50(6):1927-35. PubMed ID: 22518869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results.
    Isidean SD; Mayrand MH; Ramanakumar AV; Rodrigues I; Ferenczy A; Ratnam S; Coutlée F; Franco EL;
    Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):923-929. PubMed ID: 28096198
    [No Abstract]   [Full Text] [Related]  

  • 19. The Triage of Women with ASCUS Cytology Using Human Papillomavirus DNA Testing.
    Kuperman L; Krumholz BA
    J Low Genit Tract Dis; 2000 Jan; 4(1):1-6. PubMed ID: 25950782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.
    Persson M; Elfström KM; Brismar Wendel S; Weiderpass E; Andersson S
    PLoS One; 2014; 9(2):e90023. PubMed ID: 24587193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.